FAROTTI, LUCIA
 Distribuzione geografica
Continente #
NA - Nord America 1.072
AS - Asia 890
EU - Europa 567
SA - Sud America 127
AF - Africa 20
OC - Oceania 1
Totale 2.677
Nazione #
US - Stati Uniti d'America 1.040
SG - Singapore 436
IE - Irlanda 141
VN - Vietnam 133
CN - Cina 118
BR - Brasile 99
RU - Federazione Russa 93
HK - Hong Kong 92
IT - Italia 80
DE - Germania 53
FR - Francia 53
FI - Finlandia 25
RO - Romania 23
GB - Regno Unito 19
IN - India 18
IQ - Iraq 16
SE - Svezia 15
UA - Ucraina 14
JP - Giappone 13
MX - Messico 13
BD - Bangladesh 12
PL - Polonia 12
AT - Austria 11
TR - Turchia 11
AR - Argentina 10
CA - Canada 10
ES - Italia 6
KR - Corea 6
NL - Olanda 6
BE - Belgio 5
DZ - Algeria 5
PK - Pakistan 5
CO - Colombia 4
ID - Indonesia 4
MA - Marocco 4
VE - Venezuela 4
ZA - Sudafrica 4
CZ - Repubblica Ceca 3
EC - Ecuador 3
JM - Giamaica 3
LY - Libia 3
NP - Nepal 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
AL - Albania 2
AM - Armenia 2
CH - Svizzera 2
IL - Israele 2
JO - Giordania 2
PY - Paraguay 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
BF - Burkina Faso 1
BO - Bolivia 1
CL - Cile 1
CR - Costa Rica 1
DK - Danimarca 1
DM - Dominica 1
EE - Estonia 1
ET - Etiopia 1
GT - Guatemala 1
GY - Guiana 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MM - Myanmar 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
RS - Serbia 1
RW - Ruanda 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
Totale 2.677
Città #
Singapore 339
Chandler 210
Dublin 141
Hong Kong 92
San Jose 83
Dong Ket 75
Ashburn 59
San Mateo 51
Altamura 37
Santa Clara 35
Boardman 32
Wilmington 32
Beijing 31
Medford 29
Moscow 29
Princeton 28
Des Moines 27
Lawrence 27
Los Angeles 27
Lauterbourg 26
Perugia 24
Ann Arbor 22
Hanoi 20
Timisoara 18
Frankfurt am Main 17
Andover 14
Munich 14
The Dalles 11
Tokyo 11
Falls Church 10
Ho Chi Minh City 10
Saint Petersburg 10
New York 9
Orem 9
Dallas 8
São Paulo 8
Baghdad 7
Norwalk 7
Nuremberg 7
Turku 7
Helsinki 6
Lappeenranta 6
Seoul 6
Stockholm 6
Warsaw 6
Brooklyn 5
Brussels 5
Bucharest 5
Chennai 5
Columbus 5
Denver 5
San Francisco 5
San Paolo di Civitate 5
Toronto 5
Falkenstein 4
Poplar 4
Querétaro 4
Redwood City 4
Amsterdam 3
Brasília 3
Campinas 3
Chicago 3
Houston 3
Hải Dương 3
Istanbul 3
Johannesburg 3
London 3
Paris 3
Secaucus 3
Tashkent 3
Wroclaw 3
Zhengzhou 3
Algiers 2
Amman 2
Asunción 2
Atlanta 2
Augusta 2
Buenos Aires 2
Casablanca 2
Charlotte 2
Delhi 2
Den Haag 2
Dhaka 2
Donostia / San Sebastian 2
Duque de Caxias 2
Fairfield 2
Fremont 2
Haiphong 2
Izmir 2
Jakarta 2
Jeddah 2
Karbala 2
Kathmandu 2
Kingston 2
Madrid 2
Manchester 2
Marseille 2
Mexico City 2
Montes Claros 2
Mumbai 2
Totale 1.842
Nome #
Diagnostic performance of a fully automated chemiluminescent enzyme immunoassay for Alzheimer's disease diagnosis 133
Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI) 123
The added value of Aβ42/Aβ40 in the CSF signature for routine diagnostics of Alzheimer's disease 119
Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study 119
Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology 116
Abnormalities of resting-state EEG in patients with prodromal and overt dementia with Lewy bodies: Relation to clinical symptoms 109
Abnormal cortical neural synchronization mechanisms in quiet wakefulness are related to motor deficits, cognitive symptoms, and visual hallucinations in Parkinson's disease patients: an electroencephalographic study 102
Differential diagnosis between Alzheimer's disease and other dementias: Role of cerebrospinal fluid biomarkers 101
Unraveling Pathophysiological Mechanisms of Parkinson’s Disease: Contribution of CSF Biomarkers 100
White Matter Hyperintensities Are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers 100
Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine 96
Biomarker-based signature of alzheimer’s disease in pre-MCI individuals 95
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores 95
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry 90
Levodopa may affect cortical excitability in Parkinson's disease patients with cognitive deficits as revealed by reduced activity of cortical sources of resting state electroencephalographic rhythms 87
Late-Onset Epilepsy With Unknown Etiology: A Pilot Study on Neuropsychological Profile, Cerebrospinal Fluid Biomarkers, and Quantitative EEG Characteristics 87
Cognitive performances in patients affected by late-onset epilepsy with unknown etiology: A 12-month follow-up study 86
Abnormalities of functional cortical source connectivity of resting-state electroencephalographic alpha rhythms are similar in patients with mild cognitive impairment due to Alzheimer's and Lewy body diseases 86
Reciprocal Incremental Value of 18F-FDG-PET and Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment Patients Suspected for Alzheimer's Disease and Inconclusive First Biomarker 86
Parkinson's and Lewy body dementia CSF biomarkers 85
Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes 84
Two-year longitudinal monitoring of amnestic mild cognitive impairment patients with prodromal Alzheimer's disease using topographical biomarkers derived from functional magnetic resonance imaging and electroencephalographic activity 80
Validation of microRNAs in Cerebrospinal Fluid as Biomarkers for Different Forms of Dementia in a Multicenter Study 76
Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease. 75
Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores 75
Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson’s disease 73
Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders 72
Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study 72
Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: A 'European ADNI study' 67
Resting-State EEG Alpha Rhythms Are Related to CSF Tau Biomarkers in Prodromal Alzheimer's Disease 42
null 13
Totale 2.744
Categoria #
all - tutte 12.009
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.009


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202194 0 0 0 0 0 0 0 0 0 4 2 88
2021/2022223 4 38 0 2 11 8 7 58 8 17 35 35
2022/2023596 33 110 7 71 40 75 0 30 202 2 19 7
2023/2024169 14 21 9 7 2 0 42 3 4 15 31 21
2024/2025455 4 39 11 28 46 46 10 34 92 31 74 40
2025/20261.042 59 94 42 101 185 123 193 67 99 79 0 0
Totale 2.744